Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in BALB/c mice
- 193 Downloads
Brucellosis is one of the world’s major zoonoses. No vaccine is available for the prevention of brucellosis in human. Efforts are needed to develop an effective, safe, stable, vaccine with long lasting immunity against human brucellosis. Here, we cloned and expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in Escherichia coli and purified up to homogeneity by metal affinity chromatography. The purified rE2o is immunoreactive with brucellosis positive cattle sera. The immunogenicity and the protective potential of recombinant dihydrolipoamide succinyltransferase (rE2o) were evaluated in BALB/c mice with two different adjuvants i.e., Freund’s and aluminium hydroxide gel. Mice were tested for humoral immune response by ELISA. Cell mediated immune response was tested by lymphocyte proliferation assay and cytokine profiling. The recombinant E2o (rE2o) generated high IgG antibody and its isotypes IgG1, and induced significant production of INF-γ, IL-10 and IL-4 cytokines. The rE2o protein induced significant lymphoproliferation of splenocytes. Altogether, these results suggest that rE2o induces a mixed but a predominant Th2 type of immune response in BALB/c mice and provides partial protection against challenge with pathogenic Brucella abortus.
KeywordsBrucella abortus Aluminium hydroxide gel Dihydrolipoamide succinyltransferase Antibody isotypes Cytokine profiling
The authors are thankful to Dr. R. Vijayaraghavan, Director, DRDE, for providing all facilities and support required for this study. The authors are also thankful to Dr. B. Bhardwaj of Regional Animal Disease Diagnostics Centre, Udaipur, Rajasthan for providing the cattle sera used in the present study.
Conflict of interest
All the authors have no conflict of interest to declare.
- Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson J–J (2001) Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect Immun 69:4816–4822CrossRefGoogle Scholar
- Araya LN, Winter AJ (1990) Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum. Infect Immun 58:254–256Google Scholar
- Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH (2005) Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Infect Immun 73:8079–8088CrossRefGoogle Scholar
- Cassataro J, Pasquevich KA, Estein SM, Laplagne DA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH, Goldbaum FA (2007) A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination. Vaccine 25:4437–4446CrossRefGoogle Scholar
- Cespedes S, Andrews E, Folch H, Onate A (2000) Identification and partial characterization of a new protective antigen of Brucella abortus. J Med Microbiol 49:165–170Google Scholar
- Litwin CM, Johnson JM, Martins TB (2004) The Bartonella henselae sucB gene encodes a dihydrolipoamide succinyltransferase protein reactive with sera from patients with cat-scratch disease. J Med Microbiol 53:1221–1227Google Scholar
- Nguyen SV, To H, Yamaguchi T, Fukushi H, Hirai K (1999) Characterization of the Coxiella burnetii sucB gene encoding an immunogenic dihydrolipoamide succinyltransferase. Microbiol Immunol 43:743–749Google Scholar
- Roitt J, Brostoff J, Male D (2001) Immunology. Mosby Publications, LondonGoogle Scholar
- Velikovsky CA, Goldbaum FA, Cassataro J, Estein S, Bowden RA, Bruno L, Fossati CA, Giambartolomei GH (2003) Brucella lumazine synthase elicits a mixed Th1–Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infect Immun 71:5750–5755CrossRefGoogle Scholar
- Vemulapalli R, Cravero S, Calvert CL, Toth TE, Sriranganathan N, Boyle SM, Rossetti OL, Schurig GG (2000) Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kDa outer membrane protein of Brucella abortus. Clin Diagn Lab Immunol 7:114–118Google Scholar
- Zygmunt MS, Di’az MA, Teixeira-Gomes AP, Cloeckaert A (2001) Cloning, nucleotide sequence, and expression of the Brucella melitensis sucB gene coding for an immunogenic dihydrolipoamide succinyltransferase homologous protein. Infect Immun 69:6537–6540Google Scholar